Abstract
Prostate cancer (PC) shows a large prognostic spectrum, which ranges from the indolent to the lethal form and can be cured by two extreme therapies: “doing nothing” (“active surveillance”) or “destroying the prostate” (“radical surgical or radiotherapeutic treatment”). The gulf between these two extremes has been covered by the concept of focal therapy (FT), which is aimed at treating only the affected part of the prostate.
For more than 18 years, “prostatic transrectal thermo-ablation” (PTTA) with high-intensity focused ultrasound (HIFU) has been added to the therapeutic arsenal for treating PC. HIFU therapy requires the prostate tissue to increase in temperature to obtain coagulative necrosis.
This treatment, with the same aim of therapeutic efficacy as traditional therapy (consisting of surgery and radiotherapy), has different features: minimally invasive, reduced side effects (in terms of urinary incontinence and sexual impotence), adaptability to the concept of FT, and short hospitalisation.
The instruments available for the implementation of PTTA/HIFU are Ablatherm (EDAP-TMS, Lyon, France), Sonablate (FOCUS Surgery, Indianapolis, IN, USA), and Focal One (EDAP-TMS).
In 1996, the first treatments with the Ablatherm were carried out in patients with both localised PC and local recurrence after radiotherapy. The use of PTTA/HIFU has been recently proposed as a focal therapy at the initial stage of PC and as salvage therapy in the case of local recurrence after radical prostatectomy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
American Cancer Society (2013) Cancer facts & figs. 2013. American Cancer Society, Atlanta
van den Bergh RCN et al (2007) Prospective validation of active surveillance in prostate cancer: the PRIAS study. Eur Urol 52(6):1560–1563
Gelet A, Chapelon JY, Bouvier R, Souchon R, Pangaud C, Abdelrahim AF, Cathignol D, Dubernard JM (1996) Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol 29(2):174–183
Rewcastle JC, Gill IS (2014) High-intensity focused ultrasound for the treatment of prostate cancer. In: Image guided prostate cancer treatments, vol 255. doi:10.1007/978-3-642-40429-0_22. ©Springer-Verlag Berlin Heidelberg
Harris GR (2009) FDA regulation of clinical high intensity focused ultrasound (HIFU) devices. Engineering in Medicine and Biology Society, 2009. EMBC 2009. Annual International Conference of the IEEE. IEEE, 2009
Crouzet S et al (2014) High-intensity focused ultrasound as focal therapy of prostate cancer. Curr Opin Urol 24(3):225–230
Lynn JG, Zwemer RL, Chick AJ (1942) The biological application of focused ultrasound waves. Science 96:119–120
Fry WJ, Barnard JW, Fry FJ, Krumins RF, Brennan JF (1955) Ultrasonically produced localized selective lesions in the central nervous system. Am J Phys Med 34:413–423
Lizzi FL, Coleman DJ, Driller J, Franzen LA, Leopold M (1981) Effects of pulsed ultrasound on ocular tissue. Ultrasound Med Biol 7(3):245–252
Gelet A, Chapelon JY, Margonari J, Theillère Y, Gorry F, Souchon R, Bouvier R (1993) High-intensity focused ultrasound experimentation on human benign prostatic hypertrophy. Eur Urol 23(Suppl 1):44–47
Woodward B, Warwick R (1970) How safe is diagnostic sonar? Br J Radiol 43(514):719–725
Foster RS, Bihrle R, Sanghvi NT, Fry FJ, Donohue JP (1993) High- intensity focused ultrasound in the treatment of prostatic disease. Eur Urol 23(S1):29–33
Ter Haar G, Coussios C (2007) High-intensity focused ultrasound: physical principles and devices. Int J Hyperthermia 23:89–104
Madersbacher S, Kratzik C, Marberger M (1997) Prostatic tissue ablation by transrectal high intensity focused ultrasound: histological impact and clinical application. Ultrason Sonochem 4:175–179
Haar GT (2012) Principles of high-intensity focused ultrasound. In: Interventional oncology. Springer, New York, pp 51–63
Sapareto SA, Dewey WC (1984) Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 10:787–800
Goldberg SN, Solbiati L, Gazelle GS, Tanabe KK, Compton CC, Muller PR (1998) Treatment of intra hepatic malignancy with radio-frequency ablation: pathologic correlation in 16 patients. AJR Am J Roentgenol 170:1023–1028
Thompson S (1991) Pathologic analysis of photothermal and photochemical effects of laser-tissue interactions. Photochem Photobiol 53:825–835
Farjado LF, Egbort B, Marmor J, Hahn GM (1980) Effects of hyperthermia on a malignant tumour. Cancer 45:613–623
Linke CA, Carstensen EL, Frizzell LA, Elbadawi A, Fridd CW (1973) Localized tissue destruction by high-intensity focused ultrasound. Arch Surg 107(6):887–891
Chapelon JY, Margonari J, Theillère Y, Gorry F, Vernier F, Blanc E, Gelet A (1992) Effects of high-energy focused ultrasound on kidney tissue in the rat and the dog. Eur Urol 22:147–152
Coleman JA, Scardino PT (2013) Targeted prostate cancer ablation: energy options. Curr Opin Urol 23:123–128
Chaussy C, Thüroff S (2003) The status of high-intensity focused in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep 4:248–252
Rouviere O, Lyonnet D, Raudrant A, Colin-Pangaud C, Chapelon JY, Bouvier R et al (2001) MRI appearance of prostate following transrectal HIFU ablation of localized cancer. Eur Urol 40:265–274
Crouzet S, Murat FJ, Pommier P, Poissonnier L, Pasticier G, Rouviere O, Chapelon JY, Rabilloud M, Belot A, Mège-Lechevallier F, Tonoli-Catez H, Martin X, Gelet A (2012) Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes. Radiother Oncol 105(2):198–202. doi:10.1016/j.radonc.2012.09.014
Crouzet S, Chapelon JY, Rouvière O, Mege-Lechevallier F, Colombel M, Tonoli-Catez H, Martin X, Gelet A (2014) Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. Eur Urol 65(5):907–914. doi:10.1016/j.eururo.2013.04.039
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Conti, G.N., Paulesu, A., Maccagnano, C. (2017). Ultrasound-Guided Treatment of Prostate Cancer: High-Intensity Focused Ultrasound. In: Martino, P., Galosi, A. (eds) Atlas of Ultrasonography in Urology, Andrology, and Nephrology. Springer, Cham. https://doi.org/10.1007/978-3-319-40782-1_32
Download citation
DOI: https://doi.org/10.1007/978-3-319-40782-1_32
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-40780-7
Online ISBN: 978-3-319-40782-1
eBook Packages: MedicineMedicine (R0)